Science
Mechanism of Action
This compound acts as a photosensitizing prodrug. Following absorption into cells, Hexyl Aminolevolevulinate HCL is either directly utilized or hydrolyzed to 5-aminolevulinic acid (ALA). Both forms enter the cellular haem biosynthetic pathway, culminating in the overproduction and accumulation of protoporphyrin IX (PpIX), a highly photoactive molecule. When subsequently exposed to blue light (typically 360-450 nm), PpIX becomes activated, emitting red fluorescence for diagnostic imaging or generating reactive oxygen species to induce apoptosis in rapidly proliferating cells.
Research
Clinical Evidence
Medium confidenceN/A
Transparency
Dusting Analysis
There is no available data to assess the likelihood of 'dusting' or its typical concentration thresholds for cosmetic applications.
The Formula
Formulation
Safety
Safety Profile
Hexyl Aminolevulinate Hydrochloride (Cysview) is approved by the U.S. FDA as a prescription optical imaging agent for bladder cancer detection, not for general cosmetic use. GHS classification for the pure substance indicates it 'Causes skin irritation' (H315), 'May cause an allergic skin reaction' (H317), 'Causes serious eye irritation' (H319), and 'May cause respiratory irritation' (H335).
Your Skin
Skin Compatibility
Our Assessment
Verdict
Hexyl Aminolevulinate HCL is a prescription-only photosensitizing prodrug with potent medical applications, presenting significant irritation and sensitization risks; it is not suitable for general cosmetic formulations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources